Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar ...

“Blush had a real moment in 2025, with lots of cool girls in Korea wearing blush high up on their cheeks, right below their ...

Although holidays are associated with joy and fun, for some it is a period of emotional stress and unique problems, including ...

BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...

Discover the top 3 undervalued Capital Markets stocks for Wednesday, December 31 based on AAII’s Stock Grades.

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher— here's why.

Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.

Unsurprisingly, the management team has invested heavily in Energy Transfer with their own money. Around 10% of units are owned by insiders, a much higher ratio than the averages for the energy sector ...